Home Carboxes 1251011-05-8
1251011-05-8,MFCD14581202
Catalog No.:AA000N3U

1251011-05-8 | tert-Butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$62.00   $44.00
- +
250mg
98%
in stock  
$120.00   $84.00
- +
500mg
95%
in stock  
$191.00   $134.00
- +
1g
95%
in stock  
$272.00   $191.00
- +
5g
95%
in stock  
$1,322.00   $926.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000N3U
Chemical Name:
tert-Butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate
CAS Number:
1251011-05-8
Molecular Formula:
C11H20N2O3
Molecular Weight:
228.2881
MDL Number:
MFCD14581202
SMILES:
O=C(N1CC2(C1)OCCNC2)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
279  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  

Downstream Synthesis Route
1008526-71-3   
tert-butyl5-oxa-2,8-diazaspiro3.5nonane-2-carboxylate 

[1]ACSCombinatorialScience,2016,vol.18,p.569-574

[2]Patent:WO2020/57511,2020,A1

[1]Haftchenary,Sina;Nelson,ShawnD.;Furst,Laura;Dandapani,Sivaraman;Ferrara,StevenJ.;Bošković,ŽarkoV.;FigueroaLazú,Samuel;Guerrero,AdrianM.;Serrano,JuanC.;Crews,DemarcusK.;Brackeen,Cristina;Mowat,Jeffrey;Brumby,Thomas;Bauser,Marcus;Schreiber,StuartL.;Phillips,AndrewJ.[ACSCombinatorialScience,2016,vol.18,#9,p.569-574]

[2]CurrentPatentAssignee:SUZHOUZANRONGPHARMA-WO2020/57511,2020,A1

[3]CurrentPatentAssignee:ARVINAS-WO2022/198112,2022,A1

[1]CurrentPatentAssignee:SUZHOUZANRONGPHARMA-WO2020/57511,2020,A1Locationinpatent:Page/Pagecolumn145-147

[2]Haftchenary,Sina;Nelson,ShawnD.;Furst,Laura;Dandapani,Sivaraman;Ferrara,StevenJ.;Bošković,ŽarkoV.;FigueroaLazú,Samuel;Guerrero,AdrianM.;Serrano,JuanC.;Crews,DemarcusK.;Brackeen,Cristina;Mowat,Jeffrey;Brumby,Thomas;Bauser,Marcus;Schreiber,StuartL.;Phillips,AndrewJ.[ACSCombinatorialScience,2016,vol.18,#9,p.569-574]

[3]CurrentPatentAssignee:ARVINAS-WO2022/198112,2022,A1Locationinpatent:Paragraph00362

[4]CurrentPatentAssignee:ARVINAS-WO2022/198112,2022,A1Locationinpatent:Paragraph00362

[1]Haftchenary,Sina;Nelson,ShawnD.;Furst,Laura;Dandapani,Sivaraman;Ferrara,StevenJ.;Bošković,ŽarkoV.;FigueroaLazú,Samuel;Guerrero,AdrianM.;Serrano,JuanC.;Crews,DemarcusK.;Brackeen,Cristina;Mowat,Jeffrey;Brumby,Thomas;Bauser,Marcus;Schreiber,StuartL.;Phillips,AndrewJ.[ACSCombinatorialScience,2016,vol.18,#9,p.569-574]

[1]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD);MERCKKGAA-WO2019/148132,2019,A1Locationinpatent:Paragraph00951;00952;00953

[2]CurrentPatentAssignee:ARVINAS-WO2022/198112,2022,A1Locationinpatent:Paragraph00362

[3]CurrentPatentAssignee:ARVINAS-WO2022/198112,2022,A1Locationinpatent:Paragraph00362

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1251011-05-8 Molecular Formula|1251011-05-8 MDL|1251011-05-8 SMILES|1251011-05-8 tert-Butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate